Oncology Updates Archives - Cadence

Medical Communications Oncology Updates

ASCO 2024 Highlights: Advancing Cancer Care Through Innovation and Collaboration

Communications Medical Communications Oncology Updates

Anticipating ASCO: FLEX trial and MammaPrint in Breast Cancer

Communications Medical Communications Oncology Updates

Anticipating ASCO: MARIPOSA trial in Lung Cancer

Communications Medical Communications Oncology Updates

Anticipating ASCO: IMROZ trial in Multiple Myeloma

Communications FEATURED COMMUNICATION Medical Communications Oncology Updates

Cadence Hosts HR+/HER2- Breast Cancer Treatment Webinar, 9:00 AM CT, May 8

Medical Communications Oncology Updates

Exploring Breakthroughs in Sarcomas and Rare Cancers: Highlights from ESMO Congress 2024

Communications Oncology Updates

The Digital Doctor: AI Emerges as a Clinical Guide for Cancer Management

Communications Oncology Updates Patient Centered Care

ASCO GU Symposium 2024: A Quest for Better Patient Outcomes

Oncology Updates White Papers

White Paper: Immune Checkpoint Inhibitors for the Treatment of Cancer

Approval Blog Medical Communications Oncology Updates

Durvalumab receives FDA-approval as a consolidation treatment for Stage III NSCLC